(BUSINESS WIRE)--The biopharma industry must embrace a new, networked alliance model that emphasizes one convergent path combining clinical and commercial resources with market access strategy, information and capabilities, according to a newly published white paper authored by Michael Arlotto, Ph.D., Senior Vice President of Corporate Development, Quintiles.
